Navigation Links
ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy
Date:10/26/2012

nue our efforts on behalf of the California taxpayers to break new ground with our stem cell-based product that has the potential to essentially cure patients with type 1 diabetes and provide a powerful new treatment for those with type 2 disease as well."

Approval of the award came from CIRM's governing board, the Independent Citizens Oversight Committee (ICOC), with advisement from the Scientific and Medical Research Funding Working Group.  "ViaCyte has made good on their initial Disease Team award from CIRM, including a successful Pre-IND FDA meeting, and as a consequence, CIRM and the ICOC are glad to have the opportunity to continue funding ViaCyte's efforts to provide this product to patients with diabetes in California and the rest of the world," said Dr. Alan Trounson, President of CIRM.

About ViaCyte

ViaCyte is a private company focused on developing a novel cell therapy for the treatment of diabetes.  The Company's technology is based on the production of pancreatic beta cell progenitors derived from human pluripotent stem cells.  These cells are implanted using a durable and retrievable encapsulation device.  Once implanted and matured, these cells secrete insulin and other regulatory factors in response to blood glucose levels.  ViaCyte's goal is long term insulin independence without immune suppression, and without risk of hypoglycemia and other diabetes-related complications.

ViaCyte is headquartered in San Diego, California with additional operations in Athens, Georgia.  The Company is funded in part by the California Institute for Regenerative Medicine (CIRM) and JDRF.

This news release may contain forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995.

About CIRM

About CIRM: CIRM was established in November 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. The statewide bal
'/>"/>

SOURCE ViaCyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules
2. Intelomed Receives FDA 510(k) Clearance of CVInsight Medical Device
3. VirtualScopics Receives Issuance of Influential Patent in Canada
4. Lifeline Biotechnologies Receives Third Software Patent
5. Dehaier Medical Receives SFDA Approval for DHR-CPAP-C5
6. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
7. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
8. NeuroSigma Receives CE Certification
9. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
10. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
11. NxStage Patient and Advocate Brian Hess Receives Prestigious Honor from American Association of Kidney Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... HERZLIYA PITUACH, Israel , Dec. 15, 2014 ... IMNP ) announced today that its Board of Directors has ... Daniel Teper who continues as Chief Executive Officer ... Board of Directors since 2013. Immune,s new Chairman, ... represent the interest of shareholders and to continue to support ...
(Date:12/15/2014)... , December 15, 2014 Investor-Edge ... ZGNX ), Eli Lilly and Company (NYSE: ... Sanofi (NYSE: SNY ), and Novartis AG (NYSE: ... can be accessed at: http://investor-edge.com/register . On ... down 1.16%, the Dow Jones Industrial Average lost 1.79%, to ...
(Date:12/15/2014)... Government of Ghana has endorsed a project ... Terumo BCT to respond to the emerging Ebola crisis within ... system capacity to the citizens of Ghana . ... and Resilience Initiative (GERRI) is a multi-agency effort designed to: ... arrival of the Ebola epidemic , Provide new blood product ...
Breaking Medicine Technology:Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... Jan. 18, 2011 BNY Mellon and The SSI Group, ... of the alliance between the two companies, SSI,s health care ... bill payment capabilities.   Under this agreement, health ... button to the screens they use in interacting with SSI,s ...
... AUSTIN, Texas, Jan. 18, 2011 Hanger Orthopedic Group, Inc. (NYSE: ... its results of operations for the quarter ended December 31, 2010, ... issue a press release announcing the results for the quarter ended ... February 9, 2011 after the close of the market. A conference ...
Cached Medicine Technology:The SSI Group to Provide Health Care Providers with BNY Mellon's Electronic Payment Solutions 2The SSI Group to Provide Health Care Providers with BNY Mellon's Electronic Payment Solutions 3Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2010 Earnings Release Conference Call 2
(Date:12/17/2014)... Amy Norton HealthDay Reporter ... long been believed to improve overall health, but a growing ... the heart, a new review finds. In fact, the ... brisk walking, said lead researcher Paula Chu, a doctoral candidate ... review, of 37 clinical trials, found that people randomly assigned ...
(Date:12/15/2014)... NV (PRWEB) December 15, 2014 Veretekk.com, ... company, JM Ocean Avenue. JM Ocean Avenue has ... the Veretekk online automated marketing system. JM Ocean ... June 2014 merger of Ocean Avenue and JM International, ... than $2 Billion per year company. , “After nearly ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss ... which is contributing to the growth in the global audiological ... of hearing loss and balance disorders are known as audiological ... speaker and amplifier. The global market is expected to grow ... period from 2014 to 2019. Some of the factors which ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 At the ... organizations AutismOne and Focus Autism ... attendees with research on the effects of toxins to ... and intervention information. , Luminaries such as Dr. ... from abroad with esteemed, credentialed colleagues of the United ...
Breaking Medicine News(10 mins):Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Substantial Deterioration of Stockholder Value under the Current Board ... for Benefit of All StockholdersCINCINNATI, Feb. 25 ... today that it has filed presentations with the Securities ... Committee,s solicitation of consents to replace the existing Board ...
... Patterson, has weighed in on the future of SBIR grants in Washington, ... wake of SBIR grants being explicitly excluded from NIH stimulus money. Federal ... , ... (PRWEB) February 25, 2009 -- Looking for funding for ...
... Inc. customer sites top 5,200 worldwide , ... N.Chelmsford, MA (PRWEB) February ... with its recent shipment to France, AMD equipment is now installed in ... customer sites now total more than 5,200 worldwide., , ,AMD Global Telemedicine ...
... the goal of eliminating smoking as the number one ... twenty six of the nation,s leading tobacco control researchers ... all tobacco products. They also called for policies ... risks by switching from the most to the least ...
... program of 75 minute Restorative Yoga (RY) classes gained positive ... emotions, and spirituality (feeling calm/peaceful) compared to the control group. ... Psycho-Oncology focusing on physical activity, shows the women ... in feelings of peace and meaning after the yoga sessions. ...
... triggered , , TUESDAY, Feb. 24 (HealthDay News) -- ... brains might help researchers learn about other autoimmune diseases ... ago, workers at pork processing plants in two states ... arms and legs. Their common bond: Each worked in ...
Cached Medicine News:Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 2Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 3Health News:The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion 2Health News:The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion 3Health News:AMD Global Telemedicine Inc. Continues Expansion into its 74th Country 2Health News:Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States 2Health News:Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States 3Health News:Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States 4Health News:Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States 5Health News:Experts in Government, Public Health, Public Policy and Science Outline Blueprint for Reducing Death and Disease From Tobacco in the United States 6Health News:Yoga provides emotional benefits to women with breast cancer 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: